Knut A. Jaeggi

1.2k total citations
20 papers, 1.0k citations indexed

About

Knut A. Jaeggi is a scholar working on Molecular Biology, Oncology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Knut A. Jaeggi has authored 20 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 8 papers in Oncology and 6 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Knut A. Jaeggi's work include Bone health and treatments (8 papers), Radiopharmaceutical Chemistry and Applications (5 papers) and Receptor Mechanisms and Signaling (5 papers). Knut A. Jaeggi is often cited by papers focused on Bone health and treatments (8 papers), Radiopharmaceutical Chemistry and Applications (5 papers) and Receptor Mechanisms and Signaling (5 papers). Knut A. Jaeggi collaborates with scholars based in Switzerland, Netherlands and United Kingdom. Knut A. Jaeggi's co-authors include Jonathan R. Green, Klaus Müller, Leo Widler, Ek. Weiss, Markus Glatt, Reto Cortesi, Johann Schmid, T. Reichstein, Willem Vaalburg and Aren van Waarde and has published in prestigious journals such as Biochemistry, Journal of Medicinal Chemistry and Journal of Bone and Mineral Research.

In The Last Decade

Knut A. Jaeggi

20 papers receiving 952 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Knut A. Jaeggi Switzerland 13 578 313 306 250 152 20 1.0k
Ashfaq Mahmood United States 15 184 0.3× 393 1.3× 501 1.6× 24 0.1× 272 1.8× 25 1.3k
J. A. Smith United States 10 788 1.4× 57 0.2× 1.1k 3.6× 171 0.7× 74 0.5× 14 1.5k
K. M. Błażewska Poland 19 315 0.5× 89 0.3× 433 1.4× 167 0.7× 30 0.2× 43 962
Irina Alho Portugal 18 411 0.7× 60 0.2× 362 1.2× 32 0.1× 72 0.5× 41 852
Nicole Moins France 21 244 0.4× 515 1.6× 371 1.2× 6 0.0× 126 0.8× 62 964
Ulrike Pfaar Switzerland 10 201 0.3× 67 0.2× 190 0.6× 61 0.2× 64 0.4× 12 568
Miroslaw Mazurczak United States 12 391 0.7× 37 0.1× 243 0.8× 37 0.1× 109 0.7× 22 772
Zhouluo Ou China 15 334 0.6× 19 0.1× 486 1.6× 19 0.1× 66 0.4× 20 1.1k
Y. Higuchi Japan 14 154 0.3× 35 0.1× 331 1.1× 166 0.7× 10 0.1× 22 831
Jonathan Bowyer United Kingdom 14 106 0.2× 15 0.0× 140 0.5× 32 0.1× 175 1.2× 20 886

Countries citing papers authored by Knut A. Jaeggi

Since Specialization
Citations

This map shows the geographic impact of Knut A. Jaeggi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Knut A. Jaeggi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Knut A. Jaeggi more than expected).

Fields of papers citing papers by Knut A. Jaeggi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Knut A. Jaeggi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Knut A. Jaeggi. The network helps show where Knut A. Jaeggi may publish in the future.

Co-authorship network of co-authors of Knut A. Jaeggi

This figure shows the co-authorship network connecting the top 25 collaborators of Knut A. Jaeggi. A scholar is included among the top collaborators of Knut A. Jaeggi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Knut A. Jaeggi. Knut A. Jaeggi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Widler, Leo, Knut A. Jaeggi, Markus Glatt, et al.. (2002). Highly Potent Geminal Bisphosphonates. From Pamidronate Disodium (Aredia) to Zoledronic Acid (Zometa). Journal of Medicinal Chemistry. 45(17). 3721–3738. 266 indexed citations
2.
Widler, Leo, Knut A. Jaeggi, & Jonathan R. Green. (1999). Amino-Substituted GEM-Bisphosphonates. Phosphorus, sulfur, and silicon and the related elements. 144(1). 5–8. 14 indexed citations
3.
Waarde, Aren van, et al.. (1998). A novel β-adrenoceptor ligand for positron emission tomography: Evaluation in experimental animals. European Journal of Pharmacology. 343(2-3). 289–296. 22 indexed citations
4.
Müller, Klaus, et al.. (1998). Effects of the bisphosphonate zoledronate on bone loss in the ovariectomized and in the adjuvant arthritic rat.. PubMed. 48(1). 81–6. 16 indexed citations
5.
Green, Jonathan R., et al.. (1997). Renal Tolerability Profile of Novel, Potent Bisphosphonates in Two Short‐Term Rat Models. Pharmacology & Toxicology. 80(5). 225–230. 77 indexed citations
7.
Boege, Fritz, Christian Dees, Knut A. Jaeggi, et al.. (1994). Synthesis and Properties of Fluorescent .beta.-Adrenoceptor Ligands. Biochemistry. 33(31). 9126–9134. 35 indexed citations
8.
Green, Jonathan R., Klaus Müller, & Knut A. Jaeggi. (1994). Preclinical pharmacology of CGP 42′446, a new, potent, heterocyclic bisphosphonate compound. Journal of Bone and Mineral Research. 9(5). 745–751. 353 indexed citations
9.
Jaeggi, Knut A., et al.. (1992). Pharmacological characterization of bisphosphonate compounds containing a basic nitrogen substituent. Bone and Mineral. 17. S12–S12. 3 indexed citations
10.
Aigbirhio, Franklin I., et al.. (1992). S-[1-(2,3-diaminophenoxy)]-3′-(N-t-butylamino)propan-2′-ol-simplified asymmetric synthesis with CD and chiral HPLC analysis. Tetrahedron Asymmetry. 3(4). 539–554. 16 indexed citations
11.
Brady, Frank, Sajinder K. Luthra, M.J. Kensett, et al.. (1991). Asymmetric synthesis of a precursor for the automated radiosynthesis of as a preferred radioligand for β-adrenergic receptors. International Journal of Radiation Applications and Instrumentation Part A Applied Radiation and Isotopes. 42(7). 621–628. 46 indexed citations
12.
Jaeggi, Knut A. & T. WINKLER. (1990). A Novel Rearrangement in the Series of GEM-Bisphos-Phonic Acids. Phosphorus, sulfur, and silicon and the related elements. 51(1-4). 287–287. 1 indexed citations
13.
Jaeggi, Knut A. & Tammo Winkler. (1990). A NOVEL REARRANGEMENT IN THE SERIES OF GEM-BISPHOSPHONIC ACIDS. Phosphorus, sulfur, and silicon and the related elements. 54(1-4). 197–202. 2 indexed citations
14.
Jaeggi, Knut A., et al.. (1988). Synthesis and characterization of CGP-12177-NBD: a fluorescent β-adrenergic receptor probe. Biochimie. 70(5). 687–694. 16 indexed citations
15.
Morita, Yutaka, et al.. (1975). Über Umwandlungen der Iboga‐Alkaloide Voacangin und Conopharyngin 154. Mitteilung über Alkaloide. Helvetica Chimica Acta. 58(1). 211–230. 6 indexed citations
16.
Jaeggi, Knut A. & Ulrich Renner. (1972). Voacanǵa‐Alkaloide VII. Desoxovobasin. Helvetica Chimica Acta. 55(2). 446–450. 1 indexed citations
17.
Pettit, George R., T. R. KASTURI, John Knight, & Knut A. Jaeggi. (1970). Steroids and related natural products. LVI. Bufadienolides. 9. Isobufalin. The Journal of Organic Chemistry. 35(5). 1410–1414. 3 indexed citations
18.
Jaeggi, Knut A., Ek. Weiss, W. Wehrli, & T. Reichstein. (1967). Die Glykoside der Wurzeln von Gongronema taylorii (SCHLTR. & RENDLE) BULLOCK. Glykoside und Aglykone, 292. Mitteilung. Helvetica Chimica Acta. 50(5). 1201–1229. 26 indexed citations
19.
KASTURI, T. R., George R. Pettit, & Knut A. Jaeggi. (1967). Synthesis of isobufalin methyl ester. Chemical Communications (London). 644–644. 2 indexed citations
20.
Jaeggi, Knut A., Ek. Weiss, & T. Reichstein. (1963). Sarcostin, vermutliche Struktur. Vorläufige Mitteilung. Glykoside und Aglykone, 248. Mitteilung. Helvetica Chimica Acta. 46(2). 694–700. 42 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026